×
개인정보 취급방침
개인정보 처리방침에 대한 내용을 입력하십시오.
×
이용약관
서비스 이용약관에 대한 내용을 입력하십시오.
Company
비전과 미션
비즈니스 Area
리더십
함께하는 사람들
연혁
Technology
Nexavant
PeptoVac®
Anti-cancer therapy with PD1 antibody
PulmonoVac®
Tissue and organ regeneration
PeptoC
Pipeline
Pipeline
Product
News & Event
News
Event
Recruit
인재상
복리후생
채용공고
Contact
Contact
Company
비전과 미션
비즈니스 Area
리더십
함께하는 사람들
연혁
Technology
Nexavant
PeptoVac®
Anti-cancer therapy with PD1 antibody
PulmonoVac®
Tissue and organ regeneration
PeptoC
Pipeline
Pipeline
Product
News & Event
News
Event
Recruit
인재상
복리후생
채용공고
Contact
Contact
ENG
Pipeline
Pipeline
Company
Business
Pipeline
News & Event
Recruit
Contact
Product
Pipeline
Product
Nexavant as an immune stimulant
1
Reference :
https://vac.niaid.nih.gov/view?id=94
2
GMP and non-GMP grades available
3
Ready for millions to ten million doses
4
TLR3 agonist and immune stimulant :
https://pubmed.ncbi.nlm.nih.gov/36761735/
5
Potent anticancer effect:
https://pubmed.ncbi.nlm.nih.gov/38136298/
6
Mixed Th1/Th2, induced CD4 and CD8
7
Highly soluble and homogenous
8
Stable for 2 years at room temperature
9
Highly compatible with other adjuvant by a simple mix
Adjuvant
Nexavant II
Oil in water formulated with Nexavant
Antigen sparing
Th1 activation
T-cell activation
Nexavant III
Alum formulated with Nexavant
Potent antigen sparing
B-cell booster
Nexavant IV
LNP formulated with Nexavant
Antigen sparing
T-cell activator
B-cell booster